Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

H1 2020 Trading Update

22 Jul 2020 07:14

RNS Number : 6852T
Itaconix PLC
22 July 2020
 

22 July 2020

Itaconix plc ("Itaconix" or "the Company")

Itaconix Grows Revenues 80% in First Half 2020

Itaconix (LSE: ITX) (OTCQB: ITXXF), a leading innovator in sustainable specialty polymers, is pleased to announce the following trading update for the half year to 30 June 2020.

Further to previous updates, the Company has continued to enjoy improved momentum with strong demand for its range of specialty polymers. Unaudited revenues for the first six months of the year were $1.1 million, representing circa 80% growth over the equivalent period in 2019 and circa 62% over the second half of 2019. As a result of the increase in revenues, unaudited LBITDA(1) has decreased in line with management's expectations.

Volumes and revenues increased from new and recurring orders in detergent, odour control, and personal care applications. Significant revenue growth has come from customers successfully launching new dishwashing products using Itaconix formulas based on the Company's new TSI 322 detergent polymer. In addition, several existing customers have increased the size of their recurring orders during the year partly to satisfy increased consumer buying related to stay-at-home practices in response to Covid-19. The Company has increased production rates to keep up with anticipated demand across an increasingly diverse customer base.

 

Net cash balances as at 30 June 2020 were $0.5 million with the Company's recent $2.2 million fundraise, completed after 30 June, not reflected in this total. The net proceeds from the fundraise are expected to provide sufficient funding for the Company until at least the end of 2021, during which the Company expects to make significant progress towards its medium-term plan to achieve break-even profitability.

 

John R. Shaw, CEO of Itaconix, stated: "Our proprietary polymers are validated as essential ingredients in a growing range of consumer products based on performance and sustainability. With demand increasing for all of our products and a $2.2 million fundraise completed, we are entering the second half of 2020 on a new revenue trajectory with a strong balance sheet. I am particularly encouraged by our progress at converting our detergent project pipeline with aggregate annual revenue potential of $20 million into new customer product launches, including the volumes under the New Wave detergent polymer agreement. Our revenue opportunities are expanding, and we look forward to the future with growing confidence."

 

1 Loss before interest, tax, depreciation and amortisation

 

Ends

For further information please contact:

Itaconix Plc

+1 (603) 775 4400

John R, Shaw, Chief Executive Officer

 

Laura Denner, Chief Financial Officer and Company Secretary

 

 

 

N+1 Singer (Nominated Adviser and Broker)

+44 (0) 207 496 3000

Peter Steel / James Moat

Tom Salvesen

 

 

About Itaconix

Itaconix plc (LSE: ITX) is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFVADIILFII
Date   Source Headline
2nd Jun 20267:00 amRNSMello 2026 Presentation and Update on Trading
1st Jun 20267:00 amRNS-RProgress in Crop Production Field Trials
29th May 20267:00 amRNS-RDevelopment of Next Generation Plant-Based Paints
27th May 20267:00 amRNS-RLaunch of New Marketing Program for Detergents
14th May 20265:55 pmRNSAdjournment of AGM
6th May 20264:46 pmRNSDirector/PDMR Shareholding
27th Apr 20266:16 pmRNSTR-1
23rd Apr 20267:00 amRNSGrants of Options & PDMR dealings
24th Mar 20267:00 amRNSPreliminary Results
28th Jan 20267:00 amRNSTR-1
16th Jan 20265:29 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFull Year Trading Update
15th Sep 20257:00 amRNSHalf Year Results
4th Sep 20257:00 amRNSNotice of Interim Results
27th Aug 20258:19 amRNSTR-1
23rd Jul 20257:00 amRNSH1 2025 Trading Update
16th Jul 20257:00 amRNS-RCroda expands agreement: sustainable odour control
1st Jul 20257:00 amRNS-RCommercial Plant-Based Product Launch
8th May 20252:20 pmRNSResult of AGM
6th May 202512:24 pmRNSTR-1
2nd May 20255:28 pmRNSNotice of AGM
1st May 20257:00 amRNSUpdate on US Tariffs
7th Apr 20257:00 amRNSGrants of Options & PDMR dealings
31st Mar 20257:00 amRNSPreliminary Results
18th Mar 20257:00 amRNSNotice of Results and Company Presentation
22nd Jan 20257:00 amRNSTrading Update
5th Nov 20247:00 amRNSTrading Update
10th Oct 20247:00 amRNSChange of Auditor
10th Sep 20247:00 amRNSHalf Year Results
2nd Sep 20247:00 amRNSNotice of Interim Results, Investor Presentation
16th Jul 20247:00 amRNSH1 2024 Trading Update
20th May 20243:03 pmRNSResult of AGM
20th May 20247:00 amRNSAGM Statement and Trading Update
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.